You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
With EMR upgrades, Penn and Rush now have structured genomic data informing clinical decision support in their precision oncology programs, but much work remains.
The company plans to offer four new products by the end of the year, including four targeted transcriptomic panels and IHC compatibility for Visium.
The companies will join their respective technologies to provide pharmacogenomic information for patients undergoing genetic testing.
The research-use-only workflow combines UgenTec's flagship FastFinder PCR diagnostics software platform and LGC Biosearch Technologies' reagents.
The methods exploit a feature of Oxford Nanopore's technology that ejects molecules mid-read, enabling a new level of control over human DNA sequencing runs.
The OpenNotes movement is encouraging experimentation as some health systems start making complete genomic reports available to patients the moment the lab signs off.
Italy's Dante Labs is building one of Europe's largest genomic labs and leading an effort to sequence 100,000 whole genomes around the Mediterranean.
The new Qlucore Diagnostics software builds on the recently updated Qlucore Omics Explorer platform, initially to help clinicians diagnose and treat leukemia.
ImiDomics has developed a platform that analyzes clinical and molecular data derived from an immune-mediated inflammatory disease biobank.
The FDA has been prodding labs performing pharmacogenetic testing, and software firms providing reports from such testing, to undergo regulatory review.
The alliance comes a few months after Shriners Hospitals established a new genomics institute in Tampa, Florida in partnership with Genome Medical.
The multi-omics analytics company is assisting drug discovery and precision medicine as the first partner of Mayo's Clinical Data Analytics Platform.
The University of Utah spinout said it will use the funding to enhance and expand its NGS-based Explify microbe identification platform and support its lab.
The company hopes to help consumer genomics firms and healthcare companies reduce the IT burdens associated with launching a new test.
The findings should spur cancer centers to review testing rates and address barriers, said experts from Hackensack University, Cota Healthcare, and Guardant Health.
The partners will use Noscendo's Disqver next-generation sequencing-based diagnostic platform to characterize antibiotic-resistant pathogens.
Quantitative Medicine has developed a computational drug discovery platform, called Core, that can predict the main effects of drugs on disease-associated targets.
The deal comes on the heels of a colorectal cancer-focused drug-discovery alliance that the German companies formed in early 2019.
The Komen Tissue Bank will use LifeOmic's Precision Health Cloud platform for genomic, clinical, and imaging data aggregation and analysis, among other things.
The companies are looking to model gene expression signatures to predict treatments for gastric cancer and improve patient stratification methodologies.
A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.
US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.
According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.
In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.